FDA Inspection 813385 — Apotex Inc.
The FDA completed an inspection of Apotex Inc. on October 26, 2012 in Richmond Hill. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 26, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Richmond Hill (Canada)